Members of the Bordetella genus alternate between two distinct phenotypic phases in response to changes in their environment. This switch, termed phenotypic modulation, is mediated by the BvgAS sensory transduction system. We developed an animal model based on the interaction of Bordetella bronchiseptica with one of its natural hosts, the rabbit. To investigate the importance of BvgAS signal transduction, we constructed constitutive (RB53) and Bvg-(RB54) phase-locked derivatives of a wild-type strain, RB50. RB50 and RB53, but not RB54, established respiratory infections in B. bronchiseptica-free rabbits with an intranasal 50% infective dose of less than 200 organisms, and the course of the infection closely resembled that observed with naturally infected rabbits. Bacteria were recovered from the nasal cavity, larynx, trachea, and lungs in similar numbers from RB50-and RB53-infected rabbits, yet no pathology was detected by histological examination of lung and tracheal sections. The antibody responses in rabbits inoculated with RB50 or RB53 were quantitatively and qualitatively indistinguishable; high titers of antibodies were generated primarily against Bvg+-phase-specific antigens. No response against flagella, a Bvg-phase factor, was detected. Assessment of bacteria associated with alveolar macrophages indicated that only a small percentage of bacteria, if any, appear to be residing within lung macrophages. We also tested the ability of these strains to survive in a nutrient poor environment, conditions which may be encountered within certain niches in the host or in an environmental reservoir. The Bvg-phase was advantageous for growth under these conditions. Our results indicate the Bvg+ phase is sufficient for establishment of respiratory tract infection in the rabbit and the normal BvgAS-mediated response to environmental signals is not required during initial colonization. The Bvg-phase may play a role at later stages of infection, including persistence, transmission, or survival in the environment.
associated with virulence are synthesized in the Bvg+ phase. In the Bvg-phase, most of these virulence factors are not expressed and in some species the phenotype of motility appears (2, 4) . While the ability of Bordetella species to undergo phenotypic modulation has been recognized for many years (22, 39) , the role of this signal transduction process in pathogenesis is still unknown.
The BvgAS sensory transduction proteins of Bordetella pertussis, the etiologic agent of whooping cough, and Bordetella bronchiseptica, which causes respiratory infections in a variety of lower animals, are 96% identical at the amino acid level (7) . BvgA and BvgS are members of a family of bacterial proteins that regulate gene expression in response to changes in environmental conditions (5, 7, 37) . The signaling pathway involves autophosphorylation of BvgS followed by phosphoryl-group transfer to BvgA (38) . During growth on artificial media, the switch from Bvg+ to Bvg'-' occurs in response to the presence of MgSO4, nicotinic acid, or low temperature (modulating Since B. pertussis exclusively infects the human respiratory tract, we chose to develop as a model the interaction between B. bronchiseptica and one of its natural hosts, the rabbit. B. bronchiseptica commonly colonizes the respiratory tract of rabbits, usually resulting in asymptomatic infections, although occasionally the upper respiratory tract disease known as snuffles and rarely bronchopneumonia occur (12, 17) . Another advantage of this model is the fact that B. bronchiseptica is motile in the Bvg-phase and therefore the flagellar filaments constitute a potential immunologic marker. Finally, since B. bronchiseptica efficiently colonizes its host while only rarely causing disease, we felt this model would allow us to identify subtle differences between strains, including both a decrease in colonization efficiency and an increase in virulence.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids are described in Table 1 and in the figure legends. B. bronchiseptica strains were grown either on Bordet-Gengou agar (BG; Difco Laboratories, Detroit, Mich.) containing 7.5% sheep blood, on L agar (33) , or in StainerScholte broth (35) . Escherichia coli strains were grown on L agar or in L broth (33) . The following additions to media were made as appropriate: 40 mM MgSO4; 10 mM nicotinic acid; 20 ,ug of gentamicin (Gm), tetracycline, or streptomycin per ml; 40 ,ug (5) . The location of the bvgS-C3 mutation resulting in an arginine-tohistidine substitution in BvgS at position 570 is shown (25) . The bvgSA54 allele consists of a 1.4-kb in-frame deletion from the unique BglII (BII) to Bcll (Bc) sites in bvgS. E, EcoRI. bility (2, 4) . Additionally, RB50 is oxidase, catalase, urease, and citrate positive and does not ferment glucose or lactose, characteristics consistent with the identification of this strain as B. bronchiseptica.
The Bvg--phase-locked mutant, RB54, was constructed as follows. The bvgAS locus from the B. bronchiseptica GP1SN strain (2) was cloned into a pBR322 derivative as a 5.2-kb EcoRI fragment. A 1.4-kb BglII-BclI fragment was removed, resulting in deletion of sequences encoding amino acids 541 to 1000, which span the second transmembrane domain, the linker, the transmitter, and most of the receiver domain (Fig.  1B) . The resulting 3.8-kb EcoRI fragment was cloned into plasmid pSS1129 (36) , and this plasmid was mobilized into B. bronchiseptica RB50. Exconjugants were selected on BG-Gmstreptomycin plates and were phenotypically Bvg+. Colonies were then stabbed into Stainer-Scholte motility agar (without modulators) and incubated at 37°C. Motile bacteria which moved out from the site of inoculation were picked and struck onto BG agar, where they formed large, flat, nonhemolytic colonies in both the presence and absence of modulating conditions (Table 1 ). These isolates were Gms, indicating resolution of the plasmid from the chromosome. Southern blot analysis indicated that the plasmid had integrated and resolved from the chromosome at the expected location.
The BvgS-constitutive strain was constructed as follows. Plasmid pIG1 contains approximately 19 kb of B. bronchiseptica DNA including the bvgAS locus on a BamHI fragment carried in pBR322 (Fig. 1B [27] ). The 2-kb StuI-BbrPI fragment which is internal to the bvgS coding region and which contains the region encoding the linker domain of bvgS was cloned into pUC19RI°(a pUC19 derivative in which the EcoRI site has been eliminated by Klenow treatment of EcoRI-digested pUC19) by use of BamHI linkers to create plasmid pEG1. The bvgS-C3 mutation, which was isolated and characterized in B. pertussis (25) , is a single-base-pair change resulting in the substitution of a His for an Arg at position 570 of the BvgS protein. This point mutation is located on a 121-bp EcoRI-BglII fragment in which the DNA sequences of B. pertussis and B. bronchiseptica are identical. The 121-bp EcoRIBglII fragment from pJMC21 (25) , containing the bvgS-C3 mutation, was swapped with that of pEG1, creating pEG3. The 2-kb BamHI fragment from pEG3 was then cloned into pSS1129 for mobilization into RB50. Exconjugants were identified as Gmr, flat, nonhemolytic colonies on BG-blood agar plates (Bvg-phenotype). Individual colonies were grown without selection in Stainer-Scholte broth and then plated on BG-blood agar plates containing 20 mM nicotinic acid (modulating conditions). Three hemolytic colonies out of approximately 8,000 colonies were identified. Two of these isolates formed small, domed, hemolytic, nonmotile colonies when grown at 25°C in the presence of 20 Animals were sacrificed 3 weeks postinoculation by intravenous injection of pentobarbital (1 ml of a 6-g/ml solution). Deep nasal swabs were obtained prior to opening of the chest cavity. Sterile techniques were used for removal of first the upper left and lower right lung lobes and then a 1-cm section of midtrachea and the larynx. These tissues were added to 5 ml of sterile PBS and homogenized in a Tekmar stomacher for 3 min. Aliquots were diluted and plated on BG agar to determine the CFU per gram of tissue. The paired differences of CFU gram-1 between wild-type and mutant strains were compared by the two-tailed t test. The remaining portion of the respiratory system was removed and inflated with formalin, and lung and trachea sections were prepared for histological examination.
For determination of secretory immunoglobulin A (IgA) and association of bacteria with alveolar macrophages, animals were sacrificed 3 weeks postinoculation as described above but instead of dissecting the respiratory tract, the trachea and lungs were removed intact. A 2-cm section of trachea was washed with 2 ml of sterile PBS, and this fluid was used for determination of anti-B. bronchiseptica IgA. Bronchoalveolar lavage (BAL) was then performed as described previously (15 Immunoelectron microscopy. Bordetella strains grown on BG-agar plates were resuspended in SCM buffer (0.15 M NaCl, 10 mM CaCl2, 10 mM MgCl,) and transferred to glow-discharged, Formvar-coated copper grids. Immunoelectron microscopy was performed as described previously (19) , with rabbit sera diluted 1:20 as the primary antibody and colloidal gold-labeled goat anti-rabbit IgG as the secondary antibody diluted 1:20. Grids were examined in an electron microscope (JEOL 100CX) at 80 kV of accelerating voltage.
Immunofluorescent staining of cytological tissue. To visualize bacteria associated with alveolar macrophages, cells from BAL fluid which adhered to glass coverslips were examined by immunofluorescence as described previously (19) , with postinfection rabbit sera diluted 1:100 as the primary antibody and fluorescein isothiocyanate-labeled anti-rabbit IgG as the secondary antibody.
RESULTS
Observations of naturally acquired B. bronchiseptica infection in rabbits. A population of 3-month-old female New Zealand White rabbits was obtained from a commercial rabbitry for intended use in respiratory infection studies. Contrary to expectations, culture of the distal nares indicated that all animals were already colonized with B. bronchiseptica. High titers of serum antibody reacting with whole cells and purified FHA were detected by ELISA and Western blots (data not shown). Our wild-type strain RB50 was isolated from the naris of one of these rabbits, passaged once on BG-blood agar and frozen, and bacteria from this stock were used as the source for all subsequent genetic manipulations and for growth of cultures for inoculation.
We took advantage of the opportunity to study the clinical course of naturally acquired B. bronchiseptica infections in a rabbit population. Upon necropsy at 3 or 5 weeks after arrival, B. bronchiseptica was recovered from the nasal cavities and (4, 27) .
Bvg+ (RB53) and Bvg-(RB54) phase-locked derivatives of RB50 were constructed by allelic exchange. RB53 (bvgS-C3) constitutively expresses Bvg+-phase characteristics and is nonmotile in the presence or absence of modulating signals due to a single-amino-acid substitution in the linker region of BvgS (Arg-570->His, Fig. 1 (Table 2) . A few rabbits inoculated with 2 x 102 or 2 x 10 CFU of RB50 or RB53 were not positive by nasal swab until day 7. All rabbits that were positive by day 7 remained positive for the duration of the experiment, and all that were negative remained negative. Rabbits were sacrificed 3 weeks postinoculation, and CFU from the larynx, trachea, and upper left and lower right lung lobes were determined. B. bronchiseptica became the predominant organism in the deep nasal cavity and larynx (>90% of culturable organisms on BG agar) in all animals which became colonized, apparently displacing the normal flora. B. bronchiseptica was also isolated from the midtrachea and lungs of all infected animals, tissues which were sterile in PBS-and RB54-inoculated animals. As shown in Fig. 2 , the patterns of colonization of the larynx, trachea, and lung lobes by RB50 or RB53 were nearly indistinguishable. The sole exception was a decrease in colonization of the left upper lung lobe in animals inoculated at the highest dose (2 x 104 CFU) with RB50 compared with RB53 colonization (P < 0.05). For animals in which infection was established, colonization levels in the respiratory tract appeared to be independent of inoculum size for both RB50 and RB53. Additionally, the numbers of bacteria isolated from the various tissues were similar to the number obtained from the naturally infected rabbits described above. In all cases, bacteria recovered from colonized animals were phenotypically identical to the inocula: Bvg-mutants were not detected in RB50-infected rabbits, and Bvgwt revertants were not found in RB53-infected animals. Clinical disease and histological examination of tracheal and lung tissue. Rabbits were monitored daily for signs of disease. All animals appeared healthy throughout the 3-week course of the experiment. Sections of trachea and lung tissue stained with hematoxylin and eosin revealed no microscopic abnormalities consistent with respiratory disease or inflammation (data not shown). Tissues of infected animals were indistinguishable from those of uninfected and control animals. Infection by both RB50 and RB53 was therefore asymptomatic, as previously observed in rabbits with naturally acquired infections. Infection of guinea pigs with wild-type B. bronchiseptica has also been shown to result in asymptomatic colonization of the respiratory tract (28) .
Quantitation of anti-Bordetella, anti-FHA, and antiflagellar antibodies by ELISA. The production of serum antibody directed against whole cells as well as phase-specific factors was examined by ELISA (Fig. 3A) . FHA was used as a marker for the Bvg+ phase, and purified flagella were used as a marker for the Bvg-phase. In all cases, infection with B. bronchiseptica was associated with a significant rise in serum IgG titers against whole cells and FHA by week 3 (Fig. 3A) . Animals inoculated with PBS or RB54 and animals that failed to become colonized after inoculation with RB50 or RB53 had only background levels of anti-Bordetella antibody. There was no significant difference between antibody titers against whole cells and against FHA in rabbits infected with either RB50 or RB53. As observed with colonization levels, antibody titers at 3 weeks postinfection were independent of the infective dose (Fig. 3A) . (Fig. 4) . Preinoculation sera and sera obtained at the time of sacrifice from rabbits inoculated with RB54 were unreactive. Sera obtained at the time of sacrifice from rabbits infected with either RB50 or RB53 reacted with a variety of Bvg+-phase-specific proteins. Figure 4 shows representative blots, with sera from rabbits inoculated with the lowest or highest dose of RB50 or RB53. All infected rabbits demonstrated similar patterns of antibody response. Relatively few proteins from Bvg--phase cells were recognized by postinoculation sera, and those that were recognized appeared to be common to both Bvg+-phase and Bvg--phase organisms. No reactivity to the 40-kDa flagellin protein synthesized by RB54 was detected in Western blots of whole-cell extracts. Purified flagellin protein was also used for Western blot analysis, and again no increase in specific reactivity against flagellin during infection was detected in the various sera (data not shown). As a control, flagellin-specific monoclonal antibody 15D8 showed strong reactivity against purified flagellin as well as flagellin protein present in wholecell extracts from Bvg--phase cells (Fig. 4) .
The antibody response against surface-exposed antigens was also examined by immunoelectron microscopy. Use of postin- oculation rabbit serum as the primary antibody was followed by use of colloidal gold-labeled anti-rabbit IgG. While many gold particles were observed decorating the bacterial cell surface, the number of gold particles associated with flagellar filaments was no greater than background (data not shown).
These results demonstrate that a major portion of the immunodominant antigens generated during respiratory tract infection are specific to the Bvg+ phase. Antibodies to Bvg--phase-specific antigens such as flagellin were not detected by ELISA, Western blot, or immunoelectron microscopy.
Distribution of B. bronchiseptica in samples obtained by BAL. It has previously been suggested that B. pertussis colonizes the lungs of rabbits as two approximately equal populations, one extracellular and the other within pulmonary macrophages (34) . In those studies, rabbits were inoculated intratracheally with very large numbers of bacteria (108 CFU [34] 
